Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Bo Yang | Cardiovascular Disease | Best Researcher Award 2025

Prof. Bo Yang | Cardiovascular Disease | Best Researcher Award

Wenzhou Medical University | China

Author Profile

Scopus

Google Scholar 

Early Academic Pursuits

Dr. Bo Yang began his academic journey with a strong foundation in the field of nutrition and health sciences. He pursued his doctoral degree at Zhejiang University through a collaborative international research program with Harvard University. This early exposure to global academic environments enabled him to acquire a multidisciplinary perspective and laid the groundwork for his career in nutritional science and lipid medicine. His academic training emphasized both molecular-level investigation and broader public health perspectives, bridging basic research with applied health outcomes.

Professional Endeavors

Following his doctoral studies, Dr. Yang expanded his expertise through postdoctoral training at China Medical University in Taiwan. These experiences enriched his understanding of advanced methodologies in nutrition and health research. He later joined Wenzhou Medical University, where he currently serves as a Research Professor and Director of the Institute of Lipids Medicine. In this leadership role, Dr. Yang oversees both research and academic development, guiding projects that integrate basic, clinical, and translational research approaches.

Contributions And Research Focus

Dr. Yang’s research centers on nutritional epidemiology, functional lipids, and health management. His work explores the role of lipid metabolism and bioactive compounds in mind-body health, with a special emphasis on how dietary interventions influence chronic disease prevention. By integrating molecular nutrition with population-based approaches, his research addresses pressing public health challenges while providing evidence for precision nutrition strategies. His expertise spans functional lipids, mind-body health, and diet-related interventions, making significant contributions to the field of nutritional sciences.

Impact And Influence

With an extensive body of published work in peer-reviewed scientific journals, Dr. Yang has established himself as a recognized voice in the field of nutrition and lipid research. His contributions include more than fifty publications in SCI-indexed journals. Beyond his own research, he actively serves as a peer reviewer for prestigious journals such as Brain, Behavior & Immunity, Food & Function, and Nutrients. His editorial role as Statistical Editor for the British Journal of Nutrition further demonstrates his influence in shaping scientific communication and ensuring methodological rigor in nutrition science.

Academic Cites

Dr. Yang’s publications have been widely cited by scholars and researchers across the globe. His contributions to nutritional epidemiology and lipid metabolism have provided reference points for emerging research in functional foods, mind-body health, and chronic disease prevention. By bridging laboratory findings with population-based studies, his work is frequently referenced in both clinical nutrition and public health research, enhancing the academic discourse in these fields.

Legacy And Future Contributions

Dr. Yang’s legacy lies in his integration of molecular nutrition with population-based health studies, offering a holistic approach to understanding the role of diet in human health. His leadership at the Institute of Lipids Medicine positions him to continue fostering innovation in nutritional research and health management. Future contributions are expected to expand into precision nutrition, functional food development, and preventive strategies for chronic diseases, influencing both academic research and public health policy.

Conclusion

Dr. Bo Yang exemplifies the qualities of an accomplished researcher and academic leader in nutritional science and lipid medicine. His career demonstrates a commitment to advancing scientific knowledge, mentoring future scholars, and addressing global health challenges through nutrition-focused solutions. With his proven track record of impactful research, editorial leadership, and international collaboration, Dr. Yang is poised to make enduring contributions to the fields of nutrition, health, and medicine.

Notable Publications

"Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate"

Authors: Jing Sun, Jingxuan Xu, Bo Yang, Keyang Chen, Yu Kong, Na Fang, Tianyu Gong, Fangyan Wang, Zongxin Ling, Jiaming Liu
Journal: Molecular nutrition & food research
Year: 2020

"Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and meta-analysis of randomised controlled trials"

Authors: Mengqing Lu, Yi Wan, Bo Yang, Catherine E Huggins, Duo Li
Journal: British Journal of Nutrition
Year: 2018

"Effects of vegetarian diets on blood lipids: a systematic review and meta‐analysis of randomized controlled trials"

Authors: Fenglei Wang, Jusheng Zheng, Bo Yang, Jiajing Jiang, Yuanqing Fu, Duo Li
Journal: Journal of the American Heart Association
Year: 2015

"Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies"

Authors: Bo Yang, Xiao-Li Ren, Yuan-Qin Fu, Jin-Long Gao, Duo Li
Journal: BMC cancer
Year: 2014

 

Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

🎓 Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

💼 Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

🥇Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

📚Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh, Tehran University of Medical Sciences, Iran

Ms. Sara Kaveh is a dedicated researcher and academic affiliated with Tehran University of Medical Sciences, Iran. Her work focuses on advancing medical research and education within the field of health sciences. She has contributed to various projects aimed at improving healthcare outcomes and is recognized for her commitment to scientific excellence and innovation.

Profile:
Education:

Ms. Sara Kaveh is a PhD candidate in Health Economics at Tehran University of Medical Sciences, where her dissertation explores regionalization models for pancreaticoduodenectomy in Iran, focusing on outcomes and costs. She earned her M.Sc. in Health Technology Assessment from Iran University of Medical Sciences, with a dissertation comparing bevacizumab and its combination with erlotinib for metastatic colorectal cancer. Earlier, she completed an M.Sc. in Health Information Technology at Kerman University of Medical Sciences, investigating the use of the Internet for health information among academic professionals. Her work integrates health economics and technology assessment to enhance healthcare delivery and policy.

Professional  Experience:

 

Ms. Sara Kaveh is currently a Research Assistant at Shiraz University of Medical Sciences, a role she began in November 2023, building on her previous tenure at the same institution from August 2019 to August 2021. From June 2017 to August 2019, she worked as an independent researcher, leading multidisciplinary teams and publishing extensively in high-impact journals. Her research spans health economics and technology assessment, contributing significantly to the academic and practical understanding of healthcare improvements.

Honors and Awards:

Ms. Sara Kaveh achieved notable academic distinctions, securing 4th place in the highly competitive Ph.D. entrance exam in Iran and 6th place in the M.Sc. entrance exam. These rankings underscore her exceptional academic capabilities and commitment to excellence in her field of health economics and technology assessment.

Top Notable Publications:

Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review

Journal: Current Therapeutic Research

Date: September 2024

DOI: 10.1016/j.curtheres.2024.100758

Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis

Journal: Journal of Telemedicine and Telecare

Date: February 2024

DOI: 10.1177/1357633X211052222

Clinical Characteristics, Laboratory Features, and Outcomes of 151 Pediatric Patients with COVID-19 and MIS-C: A Single-center Study in the Northwest of Iran

Journal: Archives of Pediatric Infectious Diseases

Date: May 7, 2023

DOI: 10.5812/pedinfect-132819

Mobile Health-Based Interventions in Self-care and Treatment Adherence in Older People: A Review Study

Journal: International Journal of Aging

Date: April 27, 2023

DOI: 10.34172/ija.2023.e6

Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2021

DOI: 10.1007/S11096-020-01146-6

WOSUID: WOS:000568149400001

Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis

Journal: Journal of Cardiovascular and Thoracic Research

Date: February 12, 2020

DOI: 10.34172/jcvtr.2020.01

Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis

Journal: Clinical Rheumatology

Date: 2020

DOI: 10.1007/S10067-020-04948-1

WOSUID: WOS:000531129700001

Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-0754-1

WOSUID: WOS:000458652000008

Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-00778-Z

WOSUID: WOS:000458652000007

Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer

DOI: 10.22037/IPA.V1I1.20015

The Efficacy of Ivabradine versus Beta Blockers in Comparison of Atenolol and Metoprolol in Patients with Mitral Stenosis in Sinus Rhythm: A Systematic Review and Meta-Analysis

DOI: 10.22037/IPA.V1I1.20006